Melanoma-associated antigen C2 is a protein that in humans is encoded by the MAGEC2gene.[1][2]
This gene is related to members of the MAGEC gene family. It is not expressed in normal tissues, except for testis, and is expressed in tumors of various histological types. This gene and the MAGEC genes are clustered on chromosome Xq26-q27.[2]
References
↑Gure AO, Stockert E, Arden KC, Boyer AD, Viars CS, Scanlan MJ, Old LJ, Chen YT (Mar 2000). "CT10: a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis". Int J Cancer. 85 (5): 726–32. doi:10.1002/(SICI)1097-0215(20000301)85:5<726::AID-IJC21>3.0.CO;2-F. PMID10699956.
Sasaki M, Nakahira K, Kawano Y, et al. (2001). "MAGE-E1, a new member of the melanoma-associated antigen gene family and its expression in human glioma". Cancer Res. 61 (12): 4809–14. PMID11406556.
Kawano Y, Sasaki M, Nakahira K, et al. (2001). "Structural characterization and chromosomal localization of the MAGE-E1 gene". Gene. 277 (1–2): 129–37. doi:10.1016/S0378-1119(01)00698-9. PMID11602350.
Wang Y, Han KJ, Pang XW, et al. (2002). "Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies". J. Immunol. 169 (2): 1102–9. doi:10.4049/jimmunol.169.2.1102. PMID12097419.
Li B, Qian XP, Pang XW, et al. (2003). "HCA587 antigen expression in normal tissues and cancers: correlation with tumor differentiation in hepatocellular carcinoma". Lab. Invest. 83 (8): 1185–92. doi:10.1097/01.LAB.0000080605.73839.96. PMID12920247.
Ma W, Germeau C, Vigneron N, et al. (2004). "Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2". Int. J. Cancer. 109 (5): 698–702. doi:10.1002/ijc.20038. PMID14999777.
Wang Y, Liang Z, Yuan YH, et al. (2004). "[Expression of multiple cancer-testis antigen genes in non-small cell lung cancer treated by chemotherapy prior surgery]". Zhonghua Yi Xue Za Zhi. 84 (6): 464–8. PMID15061963.
Godelaine D, Carrasco J, Brasseur F, et al. (2007). "A new tumor-specific antigen encoded by MAGE-C2 and presented to cytolytic T lymphocytes by HLA-B44". Cancer Immunol. Immunother. 56 (6): 753–9. doi:10.1007/s00262-006-0244-5. PMID17096150.
Yang B, Wu J, Maddodi N, et al. (2007). "Epigenetic control of MAGE gene expression by the KIT tyrosine kinase". J. Invest. Dermatol. 127 (9): 2123–8. doi:10.1038/sj.jid.5700836. PMID17495964.